YBX1 and neoplasm: Finally, in a smaller published cohort comprising matched primary and metastatic tumour samples [17], we observed that 7/9 patients had elevated YB-1 expression in their metastatic tumour compared to their matched primary tumour, further indicating potential involvement of YB-1 in the metastatic cascade (Supplementary Figure S2B).